131 related articles for article (PubMed ID: 2039842)
1. An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrences.
Zoli W; Volpi A; Bonaguri C; Riccobon A; Savini S; Brizio R; Saragoni A; Medri L; Marra GA; Amadori D
Breast Cancer Res Treat; 1991; 17(3):231-8. PubMed ID: 2039842
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay].
Kurbacher CM; Brenne U; Kurbacher JA; Mallmann P; Krebs D
Zentralbl Gynakol; 1996; 118(5):271-8. PubMed ID: 8701623
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells.
Gebarowska E; Zabel M; Majewski A; Kołodziej J
Folia Histochem Cytobiol; 1999; 37(2):135-6. PubMed ID: 10352995
[No Abstract] [Full Text] [Related]
4. Heterogeneity of drug resistance in human breast and ovarian cancers.
Kern DH
Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
[TBL] [Abstract][Full Text] [Related]
5. Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Kuffel MJ; Reid JM; Ames MM
Cancer Chemother Pharmacol; 1992; 30(1):51-7. PubMed ID: 1586980
[TBL] [Abstract][Full Text] [Related]
6. Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.
Smith HS; Zoli W; Volpi A; Hiller A; Lippman M; Swain S; Mayall B; Dollbaum C; Hackett AJ; Amadori D
Cancer Res; 1990 May; 50(10):2943-8. PubMed ID: 2334895
[TBL] [Abstract][Full Text] [Related]
7. [Human tumor clonogenic assay in human breast cancer].
Kobayashi T; Kuraishi Y; Aiba K; Inoue K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
[TBL] [Abstract][Full Text] [Related]
8. Use of an efficient method for culturing human mammary epithelial cells to study adriamycin sensitivity.
Smith HS; Hackett AJ; Lan S; Stampfer MR
Cancer Chemother Pharmacol; 1981; 6(3):237-44. PubMed ID: 7198517
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitivities of human clonogenic breast tumor cells.
Hug V; Thames H; Hortobagyi G; Finders M
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):971-81. PubMed ID: 3770053
[TBL] [Abstract][Full Text] [Related]
10. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model.
Casciari JJ; Hollingshead MG; Alley MC; Mayo JG; Malspeis L; Miyauchi S; Grever MR; Weinstein JN
J Natl Cancer Inst; 1994 Dec; 86(24):1846-52. PubMed ID: 7990159
[TBL] [Abstract][Full Text] [Related]
11. [In vitro chemosensitivity test for testicular cancer using a human tumor stem cell assay].
Yamamoto N; Matsuyama H; Shinohara Y; Shimizu K; Sakatoku J
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2229-35. PubMed ID: 2420907
[No Abstract] [Full Text] [Related]
12. Crystal structure of epidoxorubicin-formaldehyde virtual crosslink of DNA and evidence for its formation in human breast-cancer cells.
Podell ER; Harrington DJ; Taatjes DJ; Koch TH
Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1516-23. PubMed ID: 10489446
[TBL] [Abstract][Full Text] [Related]
13. In-vitro cell growth of human urothelial tumor cell lines under exposure with IL-3, GM-CSF, G-CSF and by combined administration with methotrexate, vinblastine, adriamycin and cisplatin.
Block T; Treiber U; Geffken B; Vogel M; Hanauske AR; Busch R; Hartung R
Investig Urol (Berl); 1994; 5():91-4. PubMed ID: 7536524
[No Abstract] [Full Text] [Related]
14. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
16. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro.
Drag-Zalesińska M; Wysocka T; Gebarowska E; Zabel M
Folia Histochem Cytobiol; 1999; 37(2):133-4. PubMed ID: 10352994
[No Abstract] [Full Text] [Related]
18. Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells.
Smith HS; Lippman ME; Hiller AJ; Stampfer MR; Hackett AJ
J Natl Cancer Inst; 1985 Feb; 74(2):341-7. PubMed ID: 3856048
[TBL] [Abstract][Full Text] [Related]
19. Use of cells cultured from human mammary carcinomas for studies of malignant progression and chemotherapeutic drug sensitivity.
Smith HS; Hackett AJ
J Lab Clin Med; 1987 Mar; 109(3):236-43. PubMed ID: 3819571
[TBL] [Abstract][Full Text] [Related]
20. [An in vitro chemosensitivity study using human tumor clonogenic assay in urologic malignancies].
Naito K; Hisazumi H; Asari T; Kobashi K; Amano T; Uchibayashi T
Hinyokika Kiyo; 1986 Dec; 32(12):1959-66. PubMed ID: 3825833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
